Current status and future perspectives of radiomics in hepatocellular carcinoma
- PMID: 36683711
- PMCID: PMC9850949
- DOI: 10.3748/wjg.v29.i1.43
Current status and future perspectives of radiomics in hepatocellular carcinoma
Abstract
Given the frequent co-existence of an aggressive tumor and underlying chronic liver disease, the management of hepatocellular carcinoma (HCC) patients requires experienced multidisciplinary team discussion. Moreover, imaging plays a key role in the diagnosis, staging, restaging, and surveillance of HCC. Currently, imaging assessment of HCC entails the assessment of qualitative characteristics which are prone to inter-reader variability. Radiomics is an emerging field that extracts high-dimensional mineable quantitative features that cannot be assessed visually with the naked eye from medical imaging. The main potential applications of radiomic models in HCC are to predict histology, response to treatment, genetic signature, recurrence, and survival. Despite the encouraging results to date, there are challenges and limitations that need to be overcome before radiomics implementation in clinical practice. The purpose of this article is to review the main concepts and challenges pertaining to radiomics, and to review recent studies and potential applications of radiomics in HCC.
Keywords: Hepatocellular carcinoma; Radiology; Radiomics; Texture analysis.
©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
Conflict of interest statement
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
Figures
Similar articles
-
State-of-the-art in radiomics of hepatocellular carcinoma: a review of basic principles, applications, and limitations.Abdom Radiol (NY). 2020 Feb;45(2):342-353. doi: 10.1007/s00261-019-02299-3. Abdom Radiol (NY). 2020. PMID: 31707435 Review.
-
Radiomics: A radiological evidence-based artificial intelligence technique to facilitate personalized precision medicine in hepatocellular carcinoma.Dig Liver Dis. 2023 Jul;55(7):833-847. doi: 10.1016/j.dld.2022.12.015. Epub 2023 Jan 13. Dig Liver Dis. 2023. PMID: 36641292 Review.
-
Radiomics in the diagnosis and treatment of hepatocellular carcinoma.Hepatobiliary Pancreat Dis Int. 2023 Aug;22(4):346-351. doi: 10.1016/j.hbpd.2023.03.010. Epub 2023 Mar 25. Hepatobiliary Pancreat Dis Int. 2023. PMID: 37019775 Review.
-
Radiomics machine-learning signature for diagnosis of hepatocellular carcinoma in cirrhotic patients with indeterminate liver nodules.Eur Radiol. 2020 Jan;30(1):558-570. doi: 10.1007/s00330-019-06347-w. Epub 2019 Aug 23. Eur Radiol. 2020. PMID: 31444598
-
Predicting Survival Using Pretreatment CT for Patients With Hepatocellular Carcinoma Treated With Transarterial Chemoembolization: Comparison of Models Using Radiomics.AJR Am J Roentgenol. 2018 Nov;211(5):1026-1034. doi: 10.2214/AJR.18.19507. Epub 2018 Sep 21. AJR Am J Roentgenol. 2018. PMID: 30240304
Cited by
-
Editor-in-Chief articles of choice and comments at the year-end of 2023.World J Gastroenterol. 2024 Jan 7;30(1):1-8. doi: 10.3748/wjg.v30.i1.1. World J Gastroenterol. 2024. PMID: 38293322 Free PMC article.
-
Construction of a 2.5D Deep Learning Model for Predicting Early Postoperative Recurrence of Hepatocellular Carcinoma Using Multi-View and Multi-Phase CT Images.J Hepatocell Carcinoma. 2024 Nov 16;11:2223-2239. doi: 10.2147/JHC.S493478. eCollection 2024. J Hepatocell Carcinoma. 2024. PMID: 39569409 Free PMC article.
-
A novel radiomics approach for predicting TACE outcomes in hepatocellular carcinoma patients using deep learning for multi-organ segmentation.Sci Rep. 2024 Jun 26;14(1):14779. doi: 10.1038/s41598-024-65630-z. Sci Rep. 2024. PMID: 38926517 Free PMC article.
-
Is CT Radiomics Superior to Morphological Evaluation for pN0 Characterization? A Pilot Study in Colon Cancer.Cancers (Basel). 2024 Feb 4;16(3):660. doi: 10.3390/cancers16030660. Cancers (Basel). 2024. PMID: 38339411 Free PMC article.
-
Diagnostic Performance of Selected MRI-Derived Radiomics Able to Discriminate Progression-Free and Overall Survival in Patients with Midline Glioma and the H3F3AK27M Mutation.Diagnostics (Basel). 2023 Feb 23;13(5):849. doi: 10.3390/diagnostics13050849. Diagnostics (Basel). 2023. PMID: 36899993 Free PMC article.
References
-
- Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424. - PubMed
-
- World Health Organization. Cancer fact sheets. [cited 10 August 2022]. Available from: https://gco.iarc.fr/today/fact-sheets-cancers .
-
- Llovet JM, Kelley RK, Villanueva A, Singal AG, Pikarsky E, Roayaie S, Lencioni R, Koike K, Zucman-Rossi J, Finn RS. Hepatocellular carcinoma. Nat Rev Dis Primers. 2021;7:6. - PubMed
-
- Llovet JM, Bustamante J, Castells A, Vilana R, Ayuso Mdel C, Sala M, Brú C, Rodés J, Bruix J. Natural history of untreated nonsurgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials. Hepatology. 1999;29:62–67. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical